Scholtz & Company’s Apyx Medical APYX Stock Holding History

Scholtz & Company’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$36.9K	Sell	10,000 -10,000	-50%	-$37.4K	0.02%	49
2025 Q4	$70K	Hold	20,000	–	–	0.03%	51
2025 Q3	$42.8K	Hold	20,000	–	–	0.02%	51
2025 Q2	$45K	Hold	20,000	–	–	0.02%	52
2025 Q1	$27.4K	Hold	20,000	–	–	0.01%	51
2024 Q4	$31.6K	Hold	20,000	–	–	0.02%	48
2024 Q3	$24.8K	Hold	20,000	–	–	0.01%	51
2024 Q2	$26.8K	Hold	20,000	–	–	0.01%	50
2024 Q1	$27.2K	Hold	20,000	–	–	0.01%	50
2023 Q4	$52K	Hold	20,000	–	–	0.03%	66
2023 Q3	$64K	Buy	20,000 +5,000	+33%	+$23.3K	0.04%	40
2023 Q2	$75K	Buy	15,000 +5,000	+50%	+$25.3K	0.05%	38
2023 Q1	$29K	Buy	+10,000	New	+$29.2K	0.02%	34

Other funds holding APYX

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return

SEI Investments

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return